Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

New research indicates that cannabinoids could be efficacious pain management options

by Eric W. Dolan
July 6, 2019
in Psychopharmacology
(Photo credit: Iarygin Andrii)

(Photo credit: Iarygin Andrii)

Share on TwitterShare on Facebook

Cannabis and similar substances that interact with the body’s natural cannabinoid receptors could be viable candidates for pain management and treatment, according to new research published in the journal Experimental and Clinical Psychopharmacology.

“Currently, more than 30 states have policies in place that permit medicinal cannabis use; many of these cite pain conditions as inclusionary criteria. However, despite expanding use, what we know about ‘how’ and ‘why’ cannabinoids alleviate pain remains poorly understood,” said study author Julio A. Yanes, a graduate research assistant and National Research Service Award Fellow at Auburn University.

The researchers conducted a meta-analysis of previous research that had examined cannabinoid-induced alterations in pain ratings. They identified 25 peer-reviewed studies that met their criteria, which included 2,248 participants in total.

All of the studies compared either whole-plant cannabis, cannabis extracts, or synthetic cannabinoids to a placebo.

The meta-analysis found that cannabinoid administration was associated with greater pain reduction than placebo administration.

“Although our meta-analysis results suggest that cannabinoids are efficacious pain management options, more research is needed,” Yanes told PsyPost.

“For example, our follow-up meta-regression results revealed that study sample size was associated with observed pain reduction, such that smaller samples were associated with bigger effects. Thus, large (i.e., sufficiently powered) studies are warranted.”

Scientists are learning more about how cannabis interacts with the brain and the body’s endogenous cannabinoid system. But the mechanisms behind cannabis-induced pain reduction are still unclear.

“Our meta-analysis doesn’t address ‘how’ or ‘why’ cannabinoids were more effective than placebos. One important challenge facing the field is to determine the neurobiological mechanisms that may support cannabis-related pain reduction,” Yanes said.

The study, “Effects of Cannabinoid Administration for Pain: A Meta-Analysis and Meta-Regression“, was authored by Julio A. Yanes, Zach E. McKinnell, Meredith A. Reid, Jessica N. Busler, Jesse S. Michel, Melissa M. Pangelinan, Matthew T. Sutherland, Jared W. Younger, Raul Gonzalez, and Jennifer L. Robinson.

RELATED

The tendency to feel like a perpetual victim is strongly tied to vulnerable narcissism
Addiction

Hyperarousal symptoms drive alcohol problems in male soldiers, new research suggest

January 27, 2026
New psychology research finds romantic cues reduce self-control and increase risky behavior
Artificial Intelligence

Machine learning identifies brain patterns that predict antidepressant success

January 25, 2026
Genetic factors likely confound the link between c-sections and offspring mental health
Addiction

AI identifies behavioral traits that predict alcohol preference during adolescence

January 24, 2026
Major new study finds psilocybin microdoses improve the quality of creative ideas but not the quantity
Microdosing

Major new study finds psilocybin microdoses improve the quality of creative ideas but not the quantity

January 24, 2026
Concept cells and pronouns: Neuroscientists shed light on key aspect of language comprehension
Neuroimaging

Laughing gas treatment stimulates new brain cell growth and reduces anxiety in a rodent model of PTSD

January 21, 2026
Could MDMA offer new hope for borderline personality disorder treatment?
Depression

MDMA-assisted therapy shows promise for long-term depression relief

January 20, 2026
Does psilocybin really provide long-term relief from depression, as new study suggests?
Microdosing

Psilocybin microdosing fails to boost cognitive performance in rigorous trials

January 19, 2026
In shock discovery, scientists link mother’s childhood trauma to specific molecules in her breast milk
Depression

A common side effect of antidepressants could be a surprising warning sign

January 18, 2026

STAY CONNECTED

LATEST

How AI’s distorted body ideals could contribute to body dysmorphia

Study links burnout and perfectionism to imposter phenomenon in psychiatrists

Menopause is linked to reduced gray matter and increased anxiety

Having a close friend with a gambling addiction increases personal risk, study finds

Vulnerable narcissism is strongly associated with insecure attachment, study finds

The psychology behind why we pay to avoid uncertainty

Scientists link popular convenience foods to a measurable loss of cognitive control

Conservative college students don’t face greater barriers to campus resources

RSS Psychology of Selling

  • Surprising link found between greed and poor work results among salespeople
  • Intrinsic motivation drives sales performance better than financial rewards
  • New research links faking emotions to higher turnover in B2B sales
  • How defending your opinion changes your confidence
  • The science behind why accessibility drives revenue in the fashion sector
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy